Takeda Pharmaceutical Company Limited Cash Flows From Used In Financing Activities
Takeda Pharmaceutical Company Limited (TAK) reported Cash Flows From Used In Financing Activities of -JPY 751.42 billion for the 12-month period ending 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Cash Flow › Financing Activities
ifrs-full:CashFlowsFromUsedInFinancingActivities · last filed 2025-06-25
| Period end | Cash Flows From Used In Financing Activities 12 month |
|---|---|
| 2025-03-31 | -751.42B JPY 20-F · filed 2025-06-25 |
| 2024-03-31 | -354.42B JPY 20-F · filed 2025-06-25 |
| 2023-03-31 | -709.15B JPY 20-F · filed 2025-06-25 |
| 2022-03-31 | -1.07T JPY 20-F · filed 2024-06-26 |
| 2021-03-31 | -1.09T JPY 20-F · filed 2023-06-28 |
| 2020-03-31 | -1.01T JPY 20-F · filed 2022-06-29 |
| 2019-03-31 | 2.95T JPY 20-F · filed 2021-06-29 |
| 2018-03-31 | -326.23B JPY 20-F · filed 2020-06-24 |
| 2017-03-31 | 289.90B JPY 20-F · filed 2019-06-27 |